ABT
Abbott Laboratories
NYSE · USD · Stock
$106.20
+5.25 (+5.20%)
past month
Closed- Market cap
- $183.77B
- P/E
- 39.48
- Yield
- 2.37%
- Volume
- 8.4M
- 52 weeks
- $81.97 – $132
- Dividend
About
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Abbott Laboratories (ABT) is a healthcare company listed on NYSE, traded in USD. Over the past year it moved between $81.97 and $132.03, and it pays a dividend every quarter.
- Healthcare
- Medical Devices
- Abbott Park, United States
- 122K employees
- Led by Robert B. Ford
Coming up
Dividend paid
To owners on the ex-dividend day
Financials
Revenue, last 12 months
$48.23B+14.50%
Earnings
Beat the estimate
4 of 4 quarters
Q4 2025
+0.34%
Q1 2026
+0.33%
Q2 2026
+2.61%
Q3 2026
+0.03%
Earnings per share, last 12 months $2.69
Analysts
26 analysts say
Buy
12-month target$118.52+11.60%
Dividends
Yield · per share, yearly
2.37%$2.52
Ownership
- Institutions
- 81.92%
- Insiders
- 0.49%
Latest insider trade Sep 2, 2026, MCCOY JOHN A. JR
Prices from Yahoo Finance, may be delayed